As Associate Director, Pharmacovigilance Operations, you will play a key leadership role in overseeing drug safety activities and ensuring the effective execution of pharmacovigilance operations across investigational products. You will contribute to departmental strategy while managing day-to-day safety processes, ensuring compliance with global regulatory requirements and maintaining the highest standards of patient safety. Your responsibilities will span adverse event reporting, safety database management, clinical study oversight, vendor management, and regulatory documentation. Working closely with multidisciplinary teams across Clinical Development, Clinical Operations, Medical Affairs, Biometrics, and Regulatory Affairs, you will help maintain the integrity and accuracy of clinical safety data. You will also drive operational improvements, strengthen quality systems, and support audit and inspection readiness. This is an excellent opportunity to influence drug development programs within an innovative, science-driven biotechnology environment focused on advancing treatments for psychiatric and neurological conditions.
Pharmacovigilance Strategy & Operations: Contribute to the development and implementation of pharmacovigilance operational strategies while overseeing the department's daily activities and safety processes for investigational products.
Adverse Event & Case Management: Oversee the intake, processing, medical coding, quality review, and timely regulatory reporting of Individual Case Safety Reports (ICSRs), including Serious Adverse Events (SAEs) and Suspected Unexpected Serious Adverse Reactions (SUSARs).
Clinical Study Safety Oversight: Coordinate the pharmacovigilance set-up of new clinical studies, including the development of study-specific Safety Management Plans and configuration of clinical studies within safety systems.
Safety Database Management: Ensure accurate entry, coding, reconciliation, and maintenance of adverse event information within safety databases, while establishing consistent case-processing procedures and workflows.
Medical Safety Assessment: Apply medical terminology and clinical assessment principles to evaluate adverse events, including seriousness, causality, and expectedness, in collaboration with Medical and Safety Physicians.
MedDRA Coding & Quality: Oversee MedDRA coding for adverse events and medical history, maintain coding conventions, coordinate dictionary version updates, and ensure coding accuracy and consistency.
Vendor & Service Provider Management: Select, manage, and oversee pharmacovigilance vendors and external service providers, including contractual support, performance monitoring, quality metrics, issue escalation, and deliverable management.
Regulatory Compliance: Ensure pharmacovigilance activities comply with applicable FDA, European Union, United Kingdom (MHRA), and International Council for Harmonisation (ICH) regulations, guidelines, and safety reporting requirements.
SOPs & Controlled Documentation: Develop, review, and maintain pharmacovigilance standard operating procedures (SOPs), work instructions, Safety Management Plans, and other controlled documents.
Aggregate Safety Reporting: Support the preparation and review of aggregate safety reports, including Development Safety Update Reports (DSURs), and contribute safety-related content to regulatory submissions and clinical documentation.
Safety Data Reconciliation: Coordinate safety data reconciliation activities with Data Management teams and external vendors, ensuring consistency and accuracy across clinical and safety databases.
Cross-functional Collaboration: Provide pharmacovigilance expertise and safety input during clinical study planning, document development, and cross-functional meetings. Collaborate with Biometrics, Clinical Development, Clinical Operations, Medical Affairs, and Regulatory Affairs.
Audit & Inspection Readiness: Support internal and external audits and regulatory inspections by preparing documentation, responding to findings, and coordinating corrective and preventive actions (CAPAs).
Process Improvement & Performance Monitoring: Identify opportunities to optimize pharmacovigilance workflows, implement operational improvements, and monitor and report key departmental performance metrics to management.